Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K
One-Way ANOVA: Equal Sample Sizes01:15

One-Way ANOVA: Equal Sample Sizes

3.3K
One-Way ANOVA can be performed on three or more samples with equal or unequal sample sizes. When one-way ANOVA is performed on two datasets with samples of equal sizes, it can be easily observed that the computed F statistic is highly sensitive to the sample mean.
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...
3.3K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

490
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
490
One-Way ANOVA01:18

One-Way ANOVA

7.9K
One-way ANOVA analyzes more than three samples categorized by one factor. For example, it can compare the average mileage of sports bikes. Here, the data is categorized by one factor - the company. However, one-way ANOVA cannot be used to simultaneously compare the sample mean of three or more samples categorized by two factors. An example of two factors would be sports bikes from different companies driven in different terrains, such as a desert or snowy landscape. Here, two-way ANOVA is used...
7.9K
Expected Frequencies in Goodness-of-Fit Tests01:19

Expected Frequencies in Goodness-of-Fit Tests

2.5K
A goodness-of-fit test is conducted to determine whether the observed frequency values are statistically similar to the frequencies expected for the dataset. Suppose the expected frequencies for a dataset are equal such as when predicting the frequency of any number appearing when casting a die. In that case, the expected frequency is the ratio of the total number of observations (n)  to the number of categories (k).
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age but not sex modifies lymphoid immune responses in murine sepsis.

Research square·2026
Same author

Large-scale association study identifies lung cancer susceptibility copy number variants and their potential functional role in genetic instability.

medRxiv : the preprint server for health sciences·2026
Same author

CN-RNN: a Deep Learning Framework for Copy Number Variation Detection with Exome Sequencing Data.

bioRxiv : the preprint server for biology·2026
Same author

A murine model of sepsis induces age- and sex-specific chromatin remodeling in myeloid-derived suppressor cells.

Frontiers in immunology·2026
Same author

Preterm birth skews the developmental trajectory of myeloid-derived suppressor cells in the first 48 hours of life: single-cell transcriptomics and inferred intercellular communication.

Molecular medicine (Cambridge, Mass.)·2026
Same author

A two-stage GAN-based instrumental variable method for causal analysis of omics data.

Briefings in bioinformatics·2026

Related Experiment Video

Updated: Jun 29, 2025

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
09:16

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

19.6K

OSCAA: A two-dimensional Gaussian mixture model for copy number variation association analysis.

Xuanxuan Yu1, Xizhi Luo2, Guoshuai Cai3

  • 1Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.

Genetic Epidemiology
|March 27, 2024
PubMed
Summary

A new algorithm, One-Stage CNV-disease Association Analysis (OSCAA), accurately identifies copy number variants (CNVs) linked to diseases. This method improves upon traditional approaches for genomic analysis and disease risk prediction.

Keywords:
Gaussian mixture modelcopy number variationone‐stage association testingprincipal components

More Related Videos

Detection of Copy Number Alterations Using Single Cell Sequencing
09:45

Detection of Copy Number Alterations Using Single Cell Sequencing

Published on: February 17, 2017

11.6K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.1K

Related Experiment Videos

Last Updated: Jun 29, 2025

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
09:16

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

19.6K
Detection of Copy Number Alterations Using Single Cell Sequencing
09:45

Detection of Copy Number Alterations Using Single Cell Sequencing

Published on: February 17, 2017

11.6K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.1K

Area of Science:

  • Genomics
  • Human Genetics
  • Bioinformatics

Background:

  • Copy number variants (CNVs) significantly impact genome organization and human diseases.
  • Identifying disease-associated CNVs is crucial for understanding disease pathogenesis, diagnosis, and treatment.
  • Traditional two-stage methods for CNV-disease association studies suffer from biased estimation and low statistical power.

Purpose of the Study:

  • To develop a flexible algorithm, One-Stage CNV-disease Association Analysis (OSCAA), for discovering disease-associated CNVs.
  • To simultaneously identify CNVs and evaluate their association with disease risk in a single step.
  • To account for technical biases and uncertainty in CNV detection within the statistical model.

Main Methods:

  • Developed OSCAA, a novel algorithm utilizing a two-dimensional Gaussian mixture model.
  • Incorporated principal components from copy number intensities to address technical biases.
  • Simultaneously tested CNV identification and association with quantitative and qualitative traits.

Main Results:

  • OSCAA demonstrated superior performance compared to existing one-stage and traditional two-stage methods.
  • The algorithm provided more accurate CNV-disease association estimates, particularly for short or weakly signaled CNVs.
  • Simulations confirmed OSCAA's enhanced accuracy and statistical power.

Conclusions:

  • OSCAA is a powerful and flexible approach for CNV association testing.
  • The method offers high sensitivity and specificity in identifying disease-associated CNVs.
  • OSCAA is readily applicable to diverse traits and clinical risk prediction models.